1. Home
  2. PBYI vs LAKE Comparison

PBYI vs LAKE Comparison

Compare PBYI & LAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • LAKE
  • Stock Information
  • Founded
  • PBYI 2010
  • LAKE 1982
  • Country
  • PBYI United States
  • LAKE United States
  • Employees
  • PBYI N/A
  • LAKE N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • LAKE Industrial Specialties
  • Sector
  • PBYI Health Care
  • LAKE Health Care
  • Exchange
  • PBYI Nasdaq
  • LAKE Nasdaq
  • Market Cap
  • PBYI 164.3M
  • LAKE 180.8M
  • IPO Year
  • PBYI N/A
  • LAKE 1986
  • Fundamental
  • Price
  • PBYI $3.54
  • LAKE $13.88
  • Analyst Decision
  • PBYI Strong Buy
  • LAKE Strong Buy
  • Analyst Count
  • PBYI 1
  • LAKE 3
  • Target Price
  • PBYI $7.00
  • LAKE $26.00
  • AVG Volume (30 Days)
  • PBYI 306.9K
  • LAKE 367.7K
  • Earning Date
  • PBYI 07-31-2025
  • LAKE 06-09-2025
  • Dividend Yield
  • PBYI N/A
  • LAKE 0.86%
  • EPS Growth
  • PBYI 143.51
  • LAKE N/A
  • EPS
  • PBYI 0.77
  • LAKE N/A
  • Revenue
  • PBYI $232,709,000.00
  • LAKE $177,648,000.00
  • Revenue This Year
  • PBYI N/A
  • LAKE $32.98
  • Revenue Next Year
  • PBYI N/A
  • LAKE $4.70
  • P/E Ratio
  • PBYI $4.64
  • LAKE N/A
  • Revenue Growth
  • PBYI 2.68
  • LAKE 34.28
  • 52 Week Low
  • PBYI $2.23
  • LAKE $12.76
  • 52 Week High
  • PBYI $4.13
  • LAKE $27.28
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 58.61
  • LAKE 40.44
  • Support Level
  • PBYI $3.26
  • LAKE $13.38
  • Resistance Level
  • PBYI $3.65
  • LAKE $14.20
  • Average True Range (ATR)
  • PBYI 0.14
  • LAKE 0.73
  • MACD
  • PBYI 0.01
  • LAKE 0.08
  • Stochastic Oscillator
  • PBYI 84.78
  • LAKE 44.62

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About LAKE Lakeland Industries Inc.

Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.

Share on Social Networks: